Restenosis after coronary angioplasty is a major limitation of an othe
rwise highly effective and safe procedure for the treatment of atheros
clerotic coronary artery disease. Although the advent of coronary sten
ting has reduced restenosis rates for selected patients, an overall re
stenosis rate of 20% to 25% remains. Despite numerous trials, no effec
tive pharmacologic therapy has been found. Intracoronary irradiation i
s a new technique proposed to prevent restenosis after angioplasty, In
animal models of restenosis after balloon injury, there is marked red
uction of neointimal proliferation when the injured vessel is irradiat
ed, using a variety of radiation sources and delivery systems. Early h
uman trials have underscored the importance of careful source calibrat
ion and dosimetry. A small, randomized, double-blind, placebo-controll
ed study of intracoronary irradiation to prevent recurrent restenosis
recently reported striking reductions in angiographic restenosis as we
ll as clinical event rates. A number of important issues remain unreso
lved, such as defining which component of the arterial wall serves as
the target tissue for radiation, the minimal effective dose, the maxim
um tolerable dose, and user-friendly radiation delivery systems. Furth
er studies are needed to define the safety, efficacy and the ultimate
usefulness of intracoronary irradiation as an adjunct to current proce
dures in interventional cardiology.